Product Information
CARBAMAZEPINE ER 400 MG TABLET is a generic product labeled by Ingenus Pharmaceuticals LLC, priced at $0.6070 per EA under NDC 50742025901. Its NADAC has been published 142 times since Oct 11, 2023.
Strength
400 mg/1
Manufacturer
Ingenus Pharmaceuticals LLCNDC
50742025901
Classification
Generic
Dosage Form
TABLET, EXTENDED RELEASE
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
CARBAMAZEPINEApproval Type
Generic (ANDA)
FDA Application
ANDA216404On Market Since
8/1/2023
Pharmacological Classes
Price Statistics
The NADAC for CARBAMAZEPINE ER 400 MG TABLET has been published 142 times since Oct 11, 2023, and over the history we have for it it has declined 19.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.6070 per EA |
|---|---|
| All-time high | $1.1501 (Nov 15, 2023) |
| All-time low | $0.5156 (Nov 20, 2024) |
| 52-week high | $0.7270 |
| 52-week low | $0.5655 |
| Median price | $0.7115 |
| Average price | $0.7535 |
| Largest weekly change | +52.5% (Oct 18, 2023) |
| Weeks tracked | 142 |
| Tracking since | Oct 11, 2023 |
Generic Alternatives
The matcher finds 3 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 3 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of CARBAMAZEPINE ER 400 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for CARBAMAZEPINE ER 400 MG TABLET, manufactured by Ingenus Pharmaceuticals LLC, is $0.6070 per EA (NDC 50742025901), effective Jun 24, 2026.
How has the price of CARBAMAZEPINE ER 400 MG TABLET changed over time?
Over the history we have for it, the NADAC for CARBAMAZEPINE ER 400 MG TABLET has declined 19.5%. It has been tracked across 142 weekly CMS publications since Oct 11, 2023.
What are the highest and lowest recorded NADAC prices for CARBAMAZEPINE ER 400 MG TABLET?
Since Oct 11, 2023, the NADAC for CARBAMAZEPINE ER 400 MG TABLET has ranged from a low of $0.5156 (Nov 20, 2024) to a high of $1.1501 (Nov 15, 2023), with a median of $0.7115 per EA.
Are there cheaper alternatives to CARBAMAZEPINE ER 400 MG TABLET?
3 NADAC-published products share the same active ingredient, strength, and dosage form as CARBAMAZEPINE ER 400 MG TABLET, but none are currently priced below it.
Who manufactures CARBAMAZEPINE ER 400 MG TABLET?
CARBAMAZEPINE ER 400 MG TABLET (NDC 50742025901) is labeled by Ingenus Pharmaceuticals LLC, and CMS classifies it as a generic product.
Related Drugs
Same classification